Rare genetic-disease focused firm BioMarin Pharmaceutical has added a four-storied laboratory to its Cork, Ireland facility.

Indian pharmaceutical company Intas Pharmaceuticals signed a deal to acquire Udenyca, a bone marrow stimulant used to treat low white blood-cell counts in patients who take cancer medications. Accord ...

Biotechnology company Amgen is building a $1 billion drug substance manufacturing facility in Holly Springs, North Carolina, expanding its presence in the region with its second such facility. In ...

This website (the “Site”) is operated by Informa Connect, a trading division of the Informa Group. The parent company of the Informa Group is Informa PLC. Informa Connect (“Informa Connect”, “we” or ...

Announced in 2021, the facility, named Modulus, is expected to be fully operational by 2026 and will create about 200 jobs locally. Modulus is Sanofi’s first "EVolutive vaccine facility (EVF)" outside ...

Articles In Color Color reprints are printed on 70# enamel paper and can be reproduced in color or in black and white. Color articles reprinted in black and white will be charged black and white ...

For the third quarter, Repligen reported revenue of $155 million, reflecting a 10% year-on-year increase. The organization cited its success in new modalities, sales in its contract development and ...

As of its 2023 guidance on combination and boundary products, the Australian Therapeutic Goods Administration (TGA) has provided context around key regulated product categories: Combination products ...

Pharma giant AstraZeneca announced $3.5 billion in US capital investment that will expand its biopharmaceutical researching and manufacturing footprint in the country by the end of 2026. According to ...

The firm has received a $50 million investment from Texas-based financial aid company Vitrian. This investment includes an option to increase funding up to $65 million. The initial aid will support ...

Contract development and manufacturing organization (CDMO) Celltechna, a part of the Northway Group, has broken ground on a gene therapy center in Vilnius, Lithuania. The €50 million ($54 million) ...